From January 1, 2024 to February 15, 2024, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 8,866,342 shares, representing 8.68% for $114 million under the buyback announced on November 21, 2007.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.1 USD | -0.78% | -3.41% | -13.12% |
06-17 | TD Cowen Initiates Alkermes at Buy With $34 Price Target | MT |
06-11 | Transcript : Alkermes plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:40 AM |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.12% | 4.11B | |
+38.65% | 39.1B | |
-8.62% | 38.76B | |
+26.95% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+44.87% | 14.06B | |
+34.36% | 13.12B | |
-7.14% | 11.32B | |
-12.61% | 10.68B |
- Stock Market
- Equities
- ALKS Stock
- News Alkermes plc
- Tranche Update on Alkermes plc's Equity Buyback Plan announced on November 21, 2007.